{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:09:07Z","timestamp":1779224947042,"version":"3.51.4"},"reference-count":263,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Biomed Eng"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10439-025-03963-0","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T18:53:17Z","timestamp":1767811997000},"page":"1568-1611","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Precision Nanotechnology: Revolutionizing Therapeutic Strategies Against Drug-Resistant Breast Cancer"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2404-3227","authenticated-orcid":false,"given":"ZahraSadat","family":"Razavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arefeh","family":"Mottaghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyudmila","family":"Dmitrieva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Fallahianshafiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erfan","family":"Olfat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahid","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"3963_CR1","doi-asserted-by":"crossref","unstructured":"Dhiman, V.K., M. Kumari, and D. Singh, Chemoresistance: The hidden barrier in cancer treatment. Cancer Pathogenesis and Therapy, 2025.","DOI":"10.1016\/j.cpt.2025.07.001"},{"key":"3963_CR2","doi-asserted-by":"crossref","unstructured":"Dudas, J., et al., Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio\/Chemoresistance. Cells, 2020. 9(2).","DOI":"10.3390\/cells9020428"},{"key":"3963_CR3","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.2147\/IJN.S146315","volume":"12","author":"FU Din","year":"2017","unstructured":"Din, F. U., et al. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomedicine. 12:7291\u20137309, 2017.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3963_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12951-023-01826-1","volume":"21","author":"P Shi","year":"2023","unstructured":"Shi, P., et al. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. J Nanobiotechnology. 21(1):103, 2023.","journal-title":"J Nanobiotechnology"},{"issue":"5","key":"3963_CR5","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.7150\/thno.103636","volume":"15","author":"X Shao","year":"2025","unstructured":"Shao, X., et al. Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy. Theranostics. 15(5):1689\u20131714, 2025.","journal-title":"Theranostics"},{"issue":"6","key":"3963_CR6","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1021\/acs.nanolett.8b00737","volume":"18","author":"B Sun","year":"2018","unstructured":"Sun, B., et al. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy. Nano Lett. 18(6):3643\u20133650, 2018.","journal-title":"Nano Lett"},{"key":"3963_CR7","doi-asserted-by":"crossref","unstructured":"Kazi, R.N.A., et al., Nanomedicine: The Effective Role of Nanomaterials in Healthcare from Diagnosis to Therapy. Pharmaceutics, 2025. 17(8).","DOI":"10.3390\/pharmaceutics17080987"},{"issue":"2","key":"3963_CR8","doi-asserted-by":"publisher","first-page":"388","DOI":"10.20892\/j.issn.2095-3941.2020.0328","volume":"18","author":"R Li","year":"2021","unstructured":"Li, R., et al. Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance. Cancer Biol Med. 18(2):388\u2013400, 2021.","journal-title":"Cancer Biol Med"},{"issue":"9","key":"3963_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cclet.2023.108192","volume":"34","author":"L Dong","year":"2023","unstructured":"Dong, L., et al. Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy. Chinese Chemical Letters.34(9):108192, 2023.","journal-title":"Chinese Chemical Letters"},{"key":"3963_CR10","doi-asserted-by":"crossref","unstructured":"Kinnel, B., et al., Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer. Cancers (Basel), 2023. 15(4).","DOI":"10.3390\/cancers15041320"},{"key":"3963_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-981-13-7647-4_2","volume":"1141","author":"X Liu","year":"2019","unstructured":"Liu, X. ABC Family Transporters. Adv Exp Med Biol. 1141:13\u2013100, 2019.","journal-title":"Adv Exp Med Biol"},{"key":"3963_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114346","volume":"237","author":"IF Zattoni","year":"2022","unstructured":"Zattoni, I. F., et al. Targeting breast cancer resistance protein (BCRP\/ABCG2): Functional inhibitors and expression modulators. Eur J Med Chem.237:114346, 2022.","journal-title":"Eur J Med Chem"},{"key":"3963_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2023.117486","volume":"95","author":"S Yu","year":"2023","unstructured":"Yu, S., et al. The mechanisms of multidrug resistance of breast cancer and research progress on related reversal agents. Bioorg Med Chem.95:117486, 2023.","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"3963_CR14","first-page":"515","volume":"10","author":"MS Li","year":"2017","unstructured":"Li, M. S., et al. Differential expression of breast cancer-resistance protein, lung resistance protein, and multidrug resistance protein 1 in retinas of streptozotocin-induced diabetic mice. Int J Ophthalmol. 10(4):515\u2013523, 2017.","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"3963_CR15","doi-asserted-by":"publisher","first-page":"552","DOI":"10.7150\/ijbs.76187","volume":"19","author":"L Zhang","year":"2023","unstructured":"Zhang, L., et al. Targeting Breast Cancer Stem Cells. Int J Biol Sci. 19(2):552\u2013570, 2023.","journal-title":"Int J Biol Sci"},{"key":"3963_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100851","volume":"63","author":"D Singh","year":"2022","unstructured":"Singh, D., Y. G. Assaraf, and R. N. Gacche. Long non-coding RNA mediated drug resistance in breast cancer. Drug Resist Updat.63:100851, 2022.","journal-title":"Drug Resist Updat"},{"issue":"1","key":"3963_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1158\/2767-9764.CRC-23-0330","volume":"4","author":"P Bhat-Nakshatri","year":"2024","unstructured":"Bhat-Nakshatri, P., et al. Signaling Pathway Alterations Driven by BRCA1 and BRCA2 Germline Mutations are Sufficient to Initiate Breast Tumorigenesis by the PIK3CAH1047R Oncogene. Cancer Res Commun. 4(1):38\u201354, 2024.","journal-title":"Cancer Res Commun"},{"key":"3963_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2021.111001","volume":"539","author":"V Bitsouni","year":"2022","unstructured":"Bitsouni, V., and V. Tsilidis. Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response. J Theor Biol.539:111001, 2022.","journal-title":"J Theor Biol"},{"key":"3963_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/915375","volume":"2012","author":"JH Lee","year":"2012","unstructured":"Lee, J. H., and A. Nan. Combination drug delivery approaches in metastatic breast cancer. J Drug Deliv.2012:915375, 2012.","journal-title":"J Drug Deliv"},{"issue":"1","key":"3963_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1021\/acsnano.6b05910","volume":"11","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., et al. Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles. ACS Nano. 11(1):335\u2013346, 2017.","journal-title":"ACS Nano"},{"issue":"3","key":"3963_CR21","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","volume":"18","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y., et al. Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy. Nano Lett. 18(3):1908\u20131915, 2018.","journal-title":"Nano Lett"},{"key":"3963_CR22","doi-asserted-by":"crossref","unstructured":"Gote, V., et al., Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. Int J Mol Sci, 2021. 22(9).","DOI":"10.3390\/ijms22094673"},{"issue":"4","key":"3963_CR23","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2217\/nnm.12.22","volume":"7","author":"S Vinogradov","year":"2012","unstructured":"Vinogradov, S., and X. Wei. Cancer stem cells and drug resistance: the potential of nanomedicine. Nanomedicine (Lond). 7(4):597\u2013615, 2012.","journal-title":"Nanomedicine (Lond)"},{"issue":"6","key":"3963_CR24","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/ph18060895","volume":"18","author":"A Alhazza","year":"2025","unstructured":"Alhazza, A., et al. Multidrug Resistance: Are We Still Afraid of the Big Bad Wolf. Pharmaceuticals. 18(6):895, 2025.","journal-title":"Pharmaceuticals"},{"issue":"3","key":"3963_CR25","first-page":"684","volume":"4","author":"H Zhang","year":"2021","unstructured":"Zhang, H., et al. Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer. Cancer Drug Resist. 4(3):684\u2013709, 2021.","journal-title":"Cancer Drug Resist"},{"issue":"1","key":"3963_CR26","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","volume":"10","author":"H Lee","year":"2025","unstructured":"Lee, H., et al. Cancer stem cells: landscape, challenges and emerging therapeutic innovations. Signal Transduct Target Ther. 10(1):248, 2025.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"3963_CR27","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.nano.2015.12.383","volume":"12","author":"RX Zhang","year":"2016","unstructured":"Zhang, R. X., et al. Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor. Nanomedicine. 12(5):1279\u20131290, 2016.","journal-title":"Nanomedicine"},{"issue":"17","key":"3963_CR28","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.3390\/cancers14174123","volume":"14","author":"MM Khan","year":"2022","unstructured":"Khan, M. M., and V. P. Torchilin. Recent Trends in Nanomedicine-Based Strategies to Overcome Multidrug Resistance in Tumors. Cancers. 14(17):4123, 2022.","journal-title":"Cancers"},{"issue":"2","key":"3963_CR29","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1021\/nn3044066","volume":"7","author":"H Meng","year":"2013","unstructured":"Meng, H., et al. Codelivery of an optimal drug\/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano. 7(2):994\u20131005, 2013.","journal-title":"ACS Nano"},{"key":"3963_CR30","doi-asserted-by":"crossref","unstructured":"Xu, X., et al., Large-field objective lens for multi-wavelength microscopy at mesoscale and submicron resolution. Opto-Electronic Advances, 2024. 7(6): p. 230212\u20131\u2013230212\u201316.","DOI":"10.29026\/oea.2024.230212"},{"issue":"1","key":"3963_CR31","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40364-023-00551-z","volume":"12","author":"X Chen","year":"2024","unstructured":"Chen, X., et al. Nanomaterial-encapsulated STING agonists for immune modulation in cancer therapy. Biomarker Research. 12(1):2, 2024.","journal-title":"Biomarker Research"},{"issue":"14","key":"3963_CR32","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s00018-020-03449-3","volume":"77","author":"R Mohammadinejad","year":"2020","unstructured":"Mohammadinejad, R., et al. EMT signaling: potential contribution of CRISPR\/Cas gene editing. Cell Mol Life Sci. 77(14):2701\u20132722, 2020.","journal-title":"Cell Mol Life Sci"},{"key":"3963_CR33","doi-asserted-by":"crossref","unstructured":"Kumar, D., et al., Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis. Journal of Investigative Dermatology, 2016. 136.","DOI":"10.1016\/j.jid.2016.07.024"},{"issue":"1","key":"3963_CR34","doi-asserted-by":"publisher","first-page":"26875","DOI":"10.1038\/s41598-025-12299-7","volume":"15","author":"S Nechat","year":"2025","unstructured":"Nechat, S., et al. An epithelial cell culture model for sturgeon integument responds sensitively to 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure. Scientific Reports. 15(1):26875, 2025.","journal-title":"Scientific Reports"},{"issue":"13","key":"3963_CR35","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.7150\/thno.59342","volume":"11","author":"X Wei","year":"2021","unstructured":"Wei, X., et al. Multifunctional nanoplatforms co-delivering combinatorial dual-drug for eliminating cancer multidrug resistance. Theranostics. 11(13):6334\u20136354, 2021.","journal-title":"Theranostics"},{"issue":"25","key":"3963_CR36","doi-asserted-by":"publisher","first-page":"7779","DOI":"10.1073\/pnas.1505629112","volume":"112","author":"X Zhu","year":"2015","unstructured":"Zhu, X., et al. Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proc Natl Acad Sci U S A. 112(25):7779\u20137784, 2015.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3963_CR37","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1080\/09205063.2025.2497623","volume":"36","author":"C-Y Zhang","year":"2025","unstructured":"Zhang, C.-Y., et al. The application progress of PAMAM dendrimer in cancer imaging and treatment. Journal of Biomaterials Science, Polymer Edition. 36(11):1638\u20131675, 2025.","journal-title":"Journal of Biomaterials Science, Polymer Edition"},{"key":"3963_CR38","doi-asserted-by":"crossref","unstructured":"Xie, X., et al., Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment. Pharmaceutics, 2023. 15(10).","DOI":"10.3390\/pharmaceutics15102483"},{"key":"3963_CR39","doi-asserted-by":"crossref","unstructured":"Cordani, M., R. Strippoli, and \u00c1. Somoza, Nanomaterials as Inhibitors of Epithelial Mesenchymal Transition in Cancer Treatment. Cancers (Basel), 2019. 12(1).","DOI":"10.3390\/cancers12010025"},{"issue":"2","key":"3963_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e24606","volume":"10","author":"A Mohammadian Farsani","year":"2024","unstructured":"Mohammadian Farsani, A., et al. Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing. Heliyon.10(2):e24606, 2024.","journal-title":"Heliyon"},{"key":"3963_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123120","volume":"358","author":"Z Razavi","year":"2024","unstructured":"Razavi, Z., et al. CRISPR innovations in tissue engineering and gene editing. Life Sciences.358:123120, 2024.","journal-title":"Life Sciences"},{"key":"3963_CR42","doi-asserted-by":"crossref","unstructured":"Hassn Mesrati, M., et al., CD44: A Multifunctional Mediator of Cancer Progression. Biomolecules, 2021. 11(12).","DOI":"10.3390\/biom11121850"},{"issue":"1","key":"3963_CR43","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan, D., et al. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 8(1):293, 2023.","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"3963_CR44","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.apsb.2020.10.005","volume":"10","author":"NB Charbe","year":"2020","unstructured":"Charbe, N. B., et al. Small interfering RNA for cancer treatment: overcoming hurdles in delivery. Acta Pharm Sin B. 10(11):2075\u20132109, 2020.","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"3963_CR45","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","volume":"9","author":"B Wang","year":"2024","unstructured":"Wang, B., et al. Current advance of nanotechnology in diagnosis and treatment for malignant tumors. Signal Transduct Target Ther. 9(1):200, 2024.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"3963_CR46","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1021\/acsabm.1c00461","volume":"4","author":"X Lin","year":"2021","unstructured":"Lin, X., et al. Modulating Repolarization of Tumor-Associated Macrophages with Targeted Therapeutic Nanoparticles as a Potential Strategy for Cancer Therapy. ACS Applied Bio Materials. 4(8):5871\u20135896, 2021.","journal-title":"ACS Applied Bio Materials"},{"key":"3963_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115973","volume":"170","author":"M Tangsiri","year":"2024","unstructured":"Tangsiri, M., et al. Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT). Biomedicine & Pharmacotherapy.170:115973, 2024.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"2","key":"3963_CR48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cclet.2021.08.090","volume":"33","author":"Y Song","year":"2022","unstructured":"Song, Y., et al. Macrophage-targeted nanomedicine for chronic diseases immunotherapy. Chinese Chemical Letters. 33(2):597\u2013612, 2022.","journal-title":"Chinese Chemical Letters"},{"key":"3963_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2024.106566","volume":"170","author":"M Hashemi","year":"2024","unstructured":"Hashemi, M., et al. Epigenetic regulation of hepatocellular carcinoma progression: MicroRNAs as therapeutic, diagnostic and prognostic factors. The International Journal of Biochemistry & Cell Biology.170:106566, 2024.","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"3963_CR50","doi-asserted-by":"publisher","first-page":"1002308","DOI":"10.37349\/etat.2025.1002308","volume":"6","author":"S Parveen","year":"2025","unstructured":"Parveen, S., et al. Nanoimmunotherapy: the smart trooper for cancer therapy. Explor Target Antitumor Ther. 6:1002308, 2025.","journal-title":"Explor Target Antitumor Ther"},{"key":"3963_CR51","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao, Y., et al. Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance. Front Mol Biosci. 7:193, 2020.","journal-title":"Front Mol Biosci"},{"key":"3963_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntm.2025.100075","volume":"4","author":"K Elumalai","year":"2025","unstructured":"Elumalai, K., and S. Srinivasan. Harnessing nanoparticle technology for precision medicine in head and neck cancer: Targeted delivery, immunomodulation, and clinical translation. Nano TransMed.4:100075, 2025.","journal-title":"Nano TransMed"},{"issue":"41","key":"3963_CR53","doi-asserted-by":"publisher","first-page":"5661","DOI":"10.1038\/onc.2017.184","volume":"36","author":"WX Peng","year":"2017","unstructured":"Peng, W. X., P. Koirala, and Y. Y. Mo. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 36(41):5661\u20135667, 2017.","journal-title":"Oncogene"},{"key":"3963_CR54","doi-asserted-by":"crossref","unstructured":"Yang, L., et al., Circular RNAs in cancer stem cells: Insights into their roles and mechanisms (Review). Int J Mol Med, 2025. 55(3).","DOI":"10.3892\/ijmm.2025.5491"},{"issue":"5","key":"3963_CR55","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s44164-023-00061-0","volume":"2","author":"KC Ashitha","year":"2023","unstructured":"Ashitha, K. C., et al. Leveraging mesoporous silica nanomaterial for optimal immunotherapeutics against cancer. In Vitro Model. 2(5):153\u2013169, 2023.","journal-title":"In Vitro Model"},{"key":"3963_CR56","doi-asserted-by":"crossref","unstructured":"Liu, Y., et al., pH-Sensitive Peptide Hydrogels as a Combination Drug Delivery System for Cancer Treatment. Pharmaceutics, 2022. 14(3).","DOI":"10.3390\/pharmaceutics14030652"},{"issue":"1","key":"3963_CR57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.7150\/thno.35568","volume":"10","author":"YX Lin","year":"2020","unstructured":"Lin, Y. X., et al. RNA Nanotechnology-Mediated Cancer Immunotherapy. Theranostics. 10(1):281\u2013299, 2020.","journal-title":"Theranostics"},{"issue":"9","key":"3963_CR58","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.7150\/thno.42260","volume":"11","author":"L Zou","year":"2021","unstructured":"Zou, L., et al. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy. Theranostics. 11(9):4171\u20134186, 2021.","journal-title":"Theranostics"},{"key":"3963_CR59","unstructured":"Razavi, Z., et al., CRISPR-Driven Biosensors: A New Frontier in Rapid and Accurate Disease Detection. Critical Reviews in Analytical Chemistry: p. 1\u201325."},{"key":"3963_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.sna.2024.115625","volume":"376","author":"Z Razavi","year":"2024","unstructured":"Razavi, Z., et al. CRISPR-microfluidics nexus: Advancing biomedical applications for understanding and detection. Sensors and Actuators A: Physical.376:115625, 2024.","journal-title":"Sensors and Actuators A: Physical"},{"issue":"13","key":"3963_CR61","doi-asserted-by":"publisher","first-page":"7131","DOI":"10.3390\/ijms25137131","volume":"25","author":"S Tardito","year":"2024","unstructured":"Tardito, S., et al. Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance. International Journal of Molecular Sciences. 25(13):7131, 2024.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"3963_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e41246","volume":"11","author":"AK Umar","year":"2025","unstructured":"Umar, A. K., et al. Complexed hyaluronic acid-based nanoparticles in cancer therapy and diagnosis: Research trends by natural language processing. Heliyon.11(1):e41246, 2025.","journal-title":"Heliyon"},{"key":"3963_CR63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","volume":"66","author":"N Bertrand","year":"2014","unstructured":"Bertrand, N., et al. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews. 66:2\u201325, 2014.","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"1","key":"3963_CR64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-023-01925-5","volume":"23","author":"M Chehelgerdi","year":"2024","unstructured":"Chehelgerdi, M., et al. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy. Mol Cancer. 23(1):9, 2024.","journal-title":"Mol Cancer"},{"issue":"5","key":"3963_CR65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tibtech.2019.12.021","volume":"38","author":"D Ho","year":"2020","unstructured":"Ho, D., et al. Enabling Technologies for Personalized and Precision Medicine. Trends Biotechnol. 38(5):497\u2013518, 2020.","journal-title":"Trends Biotechnol"},{"issue":"3","key":"3963_CR66","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","volume":"15","author":"M Ratti","year":"2020","unstructured":"Ratti, M., et al. MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside. Target Oncol. 15(3):261\u2013278, 2020.","journal-title":"Target Oncol"},{"issue":"1","key":"3963_CR67","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12672-023-00689-0","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang, C., et al. CircHIPK3 negatively regulates autophagy by blocking VCP binding to the Beclin 1 complex in bladder cancer. Discov Oncol. 14(1):86, 2023.","journal-title":"Discov Oncol"},{"issue":"1","key":"3963_CR68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/imm.13793","volume":"173","author":"ZB Wang","year":"2024","unstructured":"Wang, Z. B., et al. Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy. Immunology. 173(1):14\u201332, 2024.","journal-title":"Immunology"},{"key":"3963_CR69","doi-asserted-by":"crossref","unstructured":"Frickenstein, A.N., et al., Mesoporous Silica Nanoparticles: Properties and Strategies for Enhancing Clinical Effect. Pharmaceutics, 2021. 13(4).","DOI":"10.3390\/pharmaceutics13040570"},{"issue":"17","key":"3963_CR70","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1039\/D2NA00222A","volume":"4","author":"Y Yang","year":"2022","unstructured":"Yang, Y., and W. Sun. Recent advances in redox-responsive nanoparticles for combined cancer therapy. Nanoscale Adv. 4(17):3504\u20133516, 2022.","journal-title":"Nanoscale Adv"},{"issue":"2","key":"3963_CR71","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","volume":"22","author":"SM Swain","year":"2023","unstructured":"Swain, S. M., M. Shastry, and E. Hamilton. Targeting HER2-positive breast cancer: advances and future directions. Nat Rev Drug Discov. 22(2):101\u2013126, 2023.","journal-title":"Nat Rev Drug Discov"},{"key":"3963_CR72","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.2147\/IJN.S374247","volume":"17","author":"Y Sun","year":"2022","unstructured":"Sun, Y., et al. Ultrasound Responsive Smart Implantable Hydrogels for Targeted Delivery of Drugs: Reviewing Current Practices. Int J Nanomedicine. 17:5001\u20135026, 2022.","journal-title":"Int J Nanomedicine"},{"key":"3963_CR73","doi-asserted-by":"crossref","unstructured":"Ostadi, A., et al., Zerumbone Induces Apoptosis and Inhibits Migration of A2058 Melanoma stem-like Cells by Producing Reactive Oxygen Species, Causing G2\/M Cell Cycle Arrest, and Controlling the Expression of Genes Linked to Metastasis. Indian Journal of Clinical Biochemistry, 2024.","DOI":"10.1007\/s12291-024-01260-6"},{"issue":"5","key":"3963_CR74","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/cac2.12416","volume":"43","author":"A Goenka","year":"2023","unstructured":"Goenka, A., et al. Tumor microenvironment signaling and therapeutics in cancer progression. Cancer Commun (Lond). 43(5):525\u2013561, 2023.","journal-title":"Cancer Commun (Lond)"},{"key":"3963_CR75","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/inorganics13100337","volume":"13","author":"Z Jiang","year":"2025","unstructured":"Jiang, Z., H. Xiang, and X. Tang. Smart Inorganic Nanomaterials for Tumor Microenvironment Modulation. Inorganics. 13:337, 2025. https:\/\/doi.org\/10.3390\/inorganics13100337.","journal-title":"Inorganics."},{"issue":"23","key":"3963_CR76","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1016\/j.devcel.2025.07.014","volume":"60","author":"J Zheng","year":"2025","unstructured":"Zheng, J., et al. Dapk2 dysfunction leads to Mic60 lactylation and mitochondrial metabolic reprogramming, promoting lung cancer EGFR-TKI resistance and metastasis. Dev Cell. 60(23):3267-3284.e7, 2025.","journal-title":"Dev Cell"},{"key":"3963_CR77","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmolb.2019.00160","volume":"6","author":"E Henke","year":"2019","unstructured":"Henke, E., R. Nandigama, and S. Erg\u00fcn. Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy. Front Mol Biosci. 6:160, 2019.","journal-title":"Front Mol Biosci"},{"key":"3963_CR78","doi-asserted-by":"publisher","unstructured":"Mierke, C.T. Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells. Cells, 2024. 13, https:\/\/doi.org\/10.3390\/cells13010096.","DOI":"10.3390\/cells13010096"},{"issue":"2","key":"3963_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajps.2025.101021","volume":"20","author":"P Sandhbor","year":"2025","unstructured":"Sandhbor, P., et al. Immune response recalibration using immune therapy and biomimetic nano-therapy against high-grade gliomas and brain metastases. Asian Journal of Pharmaceutical Sciences.20(2):101021, 2025.","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"3963_CR80","doi-asserted-by":"crossref","unstructured":"Zhuang, Y., et al., Hypoxia signaling in cancer: Implications for therapeutic interventions. MedComm (2020), 2023. 4(1): e203.","DOI":"10.1002\/mco2.203"},{"key":"3963_CR81","doi-asserted-by":"crossref","unstructured":"Yang, S., Y.-N.N. Ta, and Y. Chen, Nanotechnology-enhanced immunotherapies for pancreatic ductal adenocarcinoma: challenges and opportunities. Drug Delivery and Translational Research, 2025.","DOI":"10.1007\/s13346-025-01908-7"},{"issue":"9","key":"3963_CR82","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s10439-025-03779-y","volume":"53","author":"ZS Razavi","year":"2025","unstructured":"Razavi, Z. S., et al. Lessons Learned from Liver-on-Chip Platform. Annals of Biomedical Engineering. 53(9):1993\u20132028, 2025.","journal-title":"Annals of Biomedical Engineering"},{"issue":"1","key":"3963_CR83","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","volume":"22","author":"M Chehelgerdi","year":"2023","unstructured":"Chehelgerdi, M., et al. Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. Mol Cancer. 22(1):169, 2023.","journal-title":"Mol Cancer"},{"key":"3963_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.flatc.2025.100834","volume":"50","author":"GARR Naik","year":"2025","unstructured":"Naik, G. A. R. R., et al. Synergistic combinational photothermal therapy-based approaches for cancer treatment. FlatChem.50:100834, 2025.","journal-title":"FlatChem"},{"key":"3963_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117535","volume":"290","author":"S Imtiaz","year":"2025","unstructured":"Imtiaz, S., et al. Mechanistic study of cancer drug delivery: Current techniques, limitations, and future prospects. European Journal of Medicinal Chemistry.290:117535, 2025.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"3963_CR86","doi-asserted-by":"crossref","unstructured":"Zahrasadat, R., Chapter 14 - Advantages of point-of-care detections, in Nanotechnology-Based Sensing Platforms for Illicit Drugs, S. Ganguly, et al., Editors. 2025, Elsevier. p. 301\u2013321.","DOI":"10.1016\/B978-0-443-23740-9.00014-4"},{"key":"3963_CR87","doi-asserted-by":"crossref","unstructured":"Liu, X., et al., Recent Advances of Organ-on-a-Chip in Cancer Modeling Research. Biosensors (Basel), 2022. 12(11).","DOI":"10.3390\/bios12111045"},{"key":"3963_CR88","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.2147\/OTT.S94800","volume":"8","author":"CS Chen","year":"2015","unstructured":"Chen, C. S., et al. Ultrasound-guided RNA interference targeting HIF-1 alpha improves the effects of transarterial chemoembolization in rat liver tumors. Onco Targets Ther. 8:3539\u20133548, 2015.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"3963_CR89","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s40820-021-00622-6","volume":"13","author":"Q Chen","year":"2021","unstructured":"Chen, Q., T. Sun, and C. Jiang. Recent Advancements in Nanomedicine for \u2018Cold\u2019 Tumor Immunotherapy. Nano-Micro Letters. 13(1):92, 2021.","journal-title":"Nano-Micro Letters"},{"issue":"1","key":"3963_CR90","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12951-024-02925-3","volume":"22","author":"W Cai","year":"2024","unstructured":"Cai, W., et al. Stable triangle: nanomedicine-based synergistic application of phototherapy and immunotherapy for tumor treatment. J Nanobiotechnology. 22(1):635, 2024.","journal-title":"J Nanobiotechnology"},{"issue":"1","key":"3963_CR91","doi-asserted-by":"publisher","first-page":"18007","DOI":"10.1038\/s41598-024-69119-7","volume":"14","author":"A Sarmadi","year":"2024","unstructured":"Sarmadi, A., et al. Comparative analysis of vision transformers and convolutional neural networks in osteoporosis detection from X-ray images. Scientific Reports. 14(1):18007, 2024.","journal-title":"Scientific Reports"},{"issue":"1","key":"3963_CR92","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1186\/s12951-024-03005-2","volume":"22","author":"Y Feng","year":"2024","unstructured":"Feng, Y., et al. Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy. J Nanobiotechnology. 22(1):737, 2024.","journal-title":"J Nanobiotechnology"},{"issue":"3","key":"3963_CR93","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s11224-022-02050-7","volume":"34","author":"M Shadi","year":"2023","unstructured":"Shadi, M., and S. Hamedani. A DFT approach to the adsorption of the Levodopa anti-neurodegenerative drug on pristine and Al-doped boron nitride nanotubes as a drug delivery vehicle. Structural Chemistry. 34(3):905\u2013914, 2023.","journal-title":"Structural Chemistry"},{"issue":"5","key":"3963_CR94","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.7150\/thno.69119","volume":"12","author":"Y Moon","year":"2022","unstructured":"Moon, Y., et al. Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death. Theranostics. 12(5):1999\u20132014, 2022.","journal-title":"Theranostics"},{"issue":"1","key":"3963_CR95","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12951-024-02586-2","volume":"22","author":"Y Hou","year":"2024","unstructured":"Hou, Y., et al. Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation. J Nanobiotechnology. 22(1):305, 2024.","journal-title":"J Nanobiotechnology"},{"key":"3963_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.840395","volume":"10","author":"X Jiang","year":"2022","unstructured":"Jiang, X., H. Zhao, and W. Li. Microneedle-mediated transdermal delivery of drug-carrying nanoparticles. Frontiers in Bioengineering and Biotechnology.10:840395, 2022.","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"3963_CR97","doi-asserted-by":"crossref","unstructured":"Ghasemiyeh, P. and S. Mohammadi-Samani, Potential of nanoparticles as permeation enhancers and targeted delivery options for skin: Advantages and disadvantages. Drug design, development and therapy, 2020: p. 3271\u20133289.","DOI":"10.2147\/DDDT.S264648"},{"issue":"4","key":"3963_CR98","doi-asserted-by":"publisher","first-page":"46","DOI":"10.21276\/apjhs.2022.9.4.11","volume":"9","author":"S Sukanta","year":"2022","unstructured":"Sukanta, S., and P. Chandra Sekhar. Solid Lipid Nanoparticles: Formulation, Preparation, and Characterization: A Review. Asian Pacific Journal of Health Sciences. 9(4):46\u201355, 2022.","journal-title":"Asian Pacific Journal of Health Sciences"},{"key":"3963_CR99","doi-asserted-by":"crossref","unstructured":"Singh, S., et al., Lipid nanoparticulate drug delivery systems: approaches toward improvement in therapeutic efficacy of bioactive molecules, in Drug carriers. 2022, IntechOpen.","DOI":"10.5772\/intechopen.104510"},{"key":"3963_CR100","doi-asserted-by":"crossref","unstructured":"R, L. and R. Velmurugan, A REVIEW OF NANOPARTICLE INNOVATIONS IN CANCER THERAPY: IMPLICATIONS, TARGETING MECHANISMS AND CLINICAL PROSPECTS. International Journal of Applied Pharmaceutics, 2024. 16(3): p. 43\u201355.","DOI":"10.22159\/ijap.2024v16i3.49358"},{"issue":"1","key":"3963_CR101","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/17425247.2016.1205583","volume":"14","author":"B Xiao","year":"2017","unstructured":"Xiao, B., L. Ma, and D. Merlin. Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy. Expert Opin Drug Deliv. 14(1):65\u201373, 2017.","journal-title":"Expert Opin Drug Deliv"},{"key":"3963_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-019-0540-9","volume":"17","author":"S Zhang","year":"2019","unstructured":"Zhang, S., et al. pH and redox dual-responsive nanoparticles based on disulfide-containing poly (\u03b2-amino ester) for combining chemotherapy and COX-2 inhibitor to overcome drug resistance in breast cancer. Journal of nanobiotechnology. 17:1\u201317, 2019.","journal-title":"Journal of nanobiotechnology"},{"issue":"1","key":"3963_CR103","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s11671-021-03628-6","volume":"16","author":"S Gavas","year":"2021","unstructured":"Gavas, S., S. Quazi, and T. M. Karpi\u0144ski. Nanoparticles for Cancer Therapy: Current Progress and Challenges. Nanoscale Research Letters. 16(1):173, 2021.","journal-title":"Nanoscale Research Letters"},{"issue":"1","key":"3963_CR104","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","volume":"8","author":"L Sun","year":"2023","unstructured":"Sun, L., et al. Smart nanoparticles for cancer therapy. Signal Transduction and Targeted Therapy. 8(1):418, 2023.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"3963_CR105","doi-asserted-by":"publisher","first-page":"1143102","DOI":"10.3389\/fphar.2023.1143102","volume":"14","author":"F Yang","year":"2023","unstructured":"Yang, F., et al. The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies. Frontiers in pharmacology. 14:1143102, 2023.","journal-title":"Frontiers in pharmacology"},{"issue":"6","key":"3963_CR106","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1109\/TCBB.2020.2973148","volume":"18","author":"X Li","year":"2021","unstructured":"Li, X., et al. FUNMarker: Fusion Network-Based Method to Identify Prognostic and Heterogeneous Breast Cancer Biomarkers. IEEE\/ACM Trans Comput Biol Bioinform. 18(6):2483\u20132491, 2021.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"5","key":"3963_CR107","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/iub.2215","volume":"72","author":"M Majidinia","year":"2020","unstructured":"Majidinia, M., et al. Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons. IUBMB life. 72(5):855\u2013871, 2020.","journal-title":"IUBMB life"},{"issue":"2","key":"3963_CR108","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell, M. J., et al. Engineering precision nanoparticles for drug delivery. Nature reviews drug discovery. 20(2):101\u2013124, 2021.","journal-title":"Nature reviews drug discovery"},{"key":"3963_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtchem.2023.101400","volume":"29","author":"SM Hosseini","year":"2023","unstructured":"Hosseini, S. M., et al. Theranostic polymeric nanoparticles as a new approach in cancer therapy and diagnosis: a review. Materials Today Chemistry.29:101400, 2023.","journal-title":"Materials Today Chemistry"},{"key":"3963_CR110","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Yao","year":"2020","unstructured":"Yao, Y., et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Frontiers in molecular biosciences. 7:193, 2020.","journal-title":"Frontiers in molecular biosciences"},{"key":"3963_CR111","doi-asserted-by":"crossref","unstructured":"Gupta, S.K., et al., Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncology reviews, 2020. 14(2).","DOI":"10.4081\/oncol.2020.448"},{"issue":"18","key":"3963_CR112","doi-asserted-by":"publisher","first-page":"2007672","DOI":"10.1002\/smll.202007672","volume":"17","author":"X Dong","year":"2021","unstructured":"Dong, X., et al. Synergistic combination of bioactive hydroxyapatite nanoparticles and the chemotherapeutic doxorubicin to overcome tumor multidrug resistance. Small. 17(18):2007672, 2021.","journal-title":"Small"},{"issue":"5","key":"3963_CR113","doi-asserted-by":"publisher","first-page":"2201327","DOI":"10.1002\/smtd.202201327","volume":"7","author":"X Li","year":"2023","unstructured":"Li, X., et al. Multifunctional liposomes remodeling tumor immune microenvironment for tumor chemoimmunotherapy. Small Methods. 7(5):2201327, 2023.","journal-title":"Small Methods"},{"issue":"10","key":"3963_CR114","doi-asserted-by":"publisher","first-page":"1900093","DOI":"10.1002\/adtp.201900093","volume":"2","author":"X Feng","year":"2019","unstructured":"Feng, X., et al. Smart nanotechnologies to target tumor with deep penetration depth for efficient cancer treatment and imaging. Advanced Therapeutics. 2(10):1900093, 2019.","journal-title":"Advanced Therapeutics"},{"key":"3963_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2022.100364","volume":"16","author":"M Li","year":"2022","unstructured":"Li, M., et al. Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines. Materials Today Bio.16:100364, 2022.","journal-title":"Materials Today Bio"},{"issue":"7","key":"3963_CR116","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1021\/acs.iecr.3c04310","volume":"63","author":"Y Li","year":"2024","unstructured":"Li, Y., et al. Polydopamine-Coated Self-Assembled Lipid Nanoparticles for Highly Effective Chemo-Photothermal Combination Therapy. Industrial & Engineering Chemistry Research. 63(7):3140\u20133151, 2024.","journal-title":"Industrial & Engineering Chemistry Research"},{"key":"3963_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4028\/www.scientific.net\/JNanoR.58.1","volume":"58","author":"MT Azar","year":"2019","unstructured":"Azar, M. T., N. Saglam, and M. Turk. Anti Wnt-1 monoclonal antibody\u2019s conjugated with gold nanoparticles, induced apoptosis on MCF-7 breast cancer cell lines. Journal of Nano Research. 58:1\u20139, 2019.","journal-title":"Journal of Nano Research"},{"key":"3963_CR118","doi-asserted-by":"crossref","unstructured":"Lim, S.H., G.T. Yee, and D. Khang, Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier. International Journal of Nanomedicine, 2024: p. 2529\u20132552.","DOI":"10.2147\/IJN.S450853"},{"key":"3963_CR119","doi-asserted-by":"crossref","unstructured":"Shrestha, B., et al., Gold nanoparticles mediated drug-gene combinational therapy for breast cancer treatment. International Journal of Nanomedicine, 2020: p. 8109\u20138119.","DOI":"10.2147\/IJN.S258625"},{"key":"3963_CR120","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-1-4939-7808-3_14","volume":"1776","author":"K Zhou","year":"2018","unstructured":"Zhou, K., and Q. Wang. Nanowires and Nanoparticle Chains Inside Tubular Viral Templates. Methods Mol Biol. 1776:215\u2013227, 2018.","journal-title":"Methods Mol Biol"},{"key":"3963_CR121","doi-asserted-by":"crossref","unstructured":"Mo, K., et al., Overview of Solid Lipid Nanoparticles in Breast Cancer Therapy. Pharmaceutics, 2023. 15(8).","DOI":"10.3390\/pharmaceutics15082065"},{"key":"3963_CR122","doi-asserted-by":"crossref","unstructured":"Muchtaridi, M., et al., Chitosan\/Alginate Polymeric Nanoparticle-Loaded \u03b1-Mangostin: Characterization, Cytotoxicity, and In Vivo Evaluation against Breast Cancer Cells. Polymers (Basel), 2023. 15(18).","DOI":"10.3390\/polym15183658"},{"issue":"29","key":"3963_CR123","doi-asserted-by":"publisher","first-page":"25808","DOI":"10.1021\/acsomega.3c00844","volume":"8","author":"Z Khan","year":"2023","unstructured":"Khan, Z., et al. Preparation and in Vitro Evaluation of Tamoxifen-Conjugated, Eco-Friendly, Agar-Based Hybrid Magnetic Nanoparticles for Their Potential Use in Breast Cancer Treatment. ACS Omega. 8(29):25808\u201325816, 2023.","journal-title":"ACS Omega"},{"key":"3963_CR124","doi-asserted-by":"crossref","unstructured":"Zieli\u0144ska, A., et al., Polymeric Nanoparticles: Production, Characterization, Toxicology and Ecotoxicology. Molecules, 2020. 25(16).","DOI":"10.3390\/molecules25163731"},{"key":"3963_CR125","doi-asserted-by":"crossref","unstructured":"Junnuthula, V., et al., Polymeric Micelles for Breast Cancer Therapy: Recent Updates, Clinical Translation and Regulatory Considerations. Pharmaceutics, 2022. 14(9).","DOI":"10.3390\/pharmaceutics14091860"},{"key":"3963_CR126","doi-asserted-by":"crossref","unstructured":"Alavi, M. and M. Hamidi, Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles. Drug Metab Pers Ther, 2019. 34(1).","DOI":"10.1515\/dmpt-2018-0032"},{"key":"3963_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103843","volume":"86","author":"D Han","year":"2025","unstructured":"Han, D., et al. Small extracellular vesicles orchestrated pathological communications between breast cancer cells and cardiomyocytes as a novel mechanism exacerbating anthracycline cardiotoxicity by fueling ferroptosis. Redox Biol.86:103843, 2025.","journal-title":"Redox Biol"},{"issue":"18","key":"3963_CR128","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1080\/09205063.2022.2103627","volume":"33","author":"P Kesharwani","year":"2022","unstructured":"Kesharwani, P., et al. Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics. J Biomater Sci Polym Ed. 33(18):2433\u20132471, 2022.","journal-title":"J Biomater Sci Polym Ed"},{"key":"3963_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117357","volume":"287","author":"ZS Razavi","year":"2025","unstructured":"Razavi, Z. S., F. S. Razavi, and S. S. Alizadeh. Inorganic nanoparticles and blood-brain barrier modulation: Advancing targeted neurological therapies. European Journal of Medicinal Chemistry.287:117357, 2025.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"3963_CR130","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.12659\/MSM.902538","volume":"23","author":"L Zhao","year":"2017","unstructured":"Zhao, L., et al. Nano-Hydroxyapatite-Derived Drug and Gene Co-Delivery System for Anti-Angiogenesis Therapy of Breast Cancer. Med Sci Monit. 23:4723\u20134732, 2017.","journal-title":"Med Sci Monit"},{"key":"3963_CR131","doi-asserted-by":"crossref","unstructured":"Keihan Shokooh, M., et al., Bio-Inspired and Smart Nanoparticles for Triple Negative Breast Cancer Microenvironment. Pharmaceutics, 2021. 13(2).","DOI":"10.3390\/pharmaceutics13020287"},{"issue":"1","key":"3963_CR132","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2014.02.006","volume":"347","author":"J Lee","year":"2014","unstructured":"Lee, J., et al. Gold nanoparticles in breast cancer treatment: promise and potential pitfalls. Cancer Lett. 347(1):46\u201353, 2014.","journal-title":"Cancer Lett"},{"issue":"2","key":"3963_CR133","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.drudis.2017.10.022","volume":"23","author":"N Poonia","year":"2018","unstructured":"Poonia, N., V. Lather, and D. Pandita. Mesoporous silica nanoparticles: a smart nanosystem for management of breast cancer. Drug Discov Today. 23(2):315\u2013332, 2018.","journal-title":"Drug Discov Today"},{"issue":"5","key":"3963_CR134","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/ijc.34611","volume":"153","author":"X Kuang","year":"2023","unstructured":"Kuang, X., et al. Distinct invasive patterns in situ between estrogen receptor-positive and triple-negative breast cancer through the intraductal tracking of carbon nanoparticles. Int J Cancer. 153(5):1067\u20131079, 2023.","journal-title":"Int J Cancer"},{"issue":"1","key":"3963_CR135","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1097\/CAD.0000000000001207","volume":"33","author":"Z Fakhroueian","year":"2022","unstructured":"Fakhroueian, Z., et al. Anticancer properties of novel zinc oxide quantum dot nanoparticles against breast cancer stem-like cells. Anticancer Drugs. 33(1):e311\u2013e326, 2022.","journal-title":"Anticancer Drugs"},{"issue":"16","key":"3963_CR136","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1016\/j.biomaterials.2014.02.030","volume":"35","author":"YC Tseng","year":"2014","unstructured":"Tseng, Y. C., et al. Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT\/CT imaging of lymph node metastases. Biomaterials. 35(16):4688\u20134698, 2014.","journal-title":"Biomaterials"},{"issue":"46","key":"3963_CR137","doi-asserted-by":"publisher","first-page":"51198","DOI":"10.1021\/acsami.0c13986","volume":"12","author":"J Sui","year":"2020","unstructured":"Sui, J., et al. Reversing P-glycoprotein-associated multidrug resistance of breast cancer by targeted acid-cleavable polysaccharide nanoparticles with lapatinib sensitization. ACS Applied Materials & Interfaces. 12(46):51198\u201351211, 2020.","journal-title":"ACS Applied Materials & Interfaces"},{"key":"3963_CR138","doi-asserted-by":"publisher","first-page":"1038225","DOI":"10.3389\/fimmu.2022.1038225","volume":"13","author":"X Qi","year":"2022","unstructured":"Qi, X., et al. Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer. Frontiers in Immunology. 13:1038225, 2022.","journal-title":"Frontiers in Immunology"},{"key":"3963_CR139","doi-asserted-by":"crossref","unstructured":"Ju, R., et al., Dual Sensitization Anti-Resistant Nanoparticles for Treating Refractory Breast Cancers via Apoptosis-Inducing. Drug Design, Development and Therapy, 2023: p. 403\u2013418.","DOI":"10.2147\/DDDT.S387788"},{"issue":"7","key":"3963_CR140","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3390\/pharmaceutics13071092","volume":"13","author":"D Zhu","year":"2021","unstructured":"Zhu, D., et al. A self-assembling amphiphilic peptide dendrimer-based drug delivery system for cancer therapy. Pharmaceutics. 13(7):1092, 2021.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3963_CR141","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/pharmaceutics12020096","volume":"12","author":"G-E Fathy Abd-Ellatef","year":"2020","unstructured":"Fathy Abd-Ellatef, G.-E., et al. Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells. Pharmaceutics. 12(2):96, 2020.","journal-title":"Pharmaceutics"},{"issue":"13","key":"3963_CR142","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.3390\/cancers16132478","volume":"16","author":"P Garg","year":"2024","unstructured":"Garg, P., et al. Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells. Cancers. 16(13):2478, 2024.","journal-title":"Cancers"},{"key":"3963_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-019-0559-y","volume":"17","author":"Y Dong","year":"2019","unstructured":"Dong, Y., et al. Incorporation of drug efflux inhibitor and chemotherapeutic agent into an inorganic\/organic platform for the effective treatment of multidrug resistant breast cancer. Journal of Nanobiotechnology. 17:1\u201315, 2019.","journal-title":"Journal of Nanobiotechnology"},{"issue":"8","key":"3963_CR144","doi-asserted-by":"publisher","first-page":"2102506","DOI":"10.1002\/adhm.202102506","volume":"11","author":"B Li","year":"2022","unstructured":"Li, B., et al. Photothermal conjugated polymer nanoparticles for suppressing breast tumor growth by regulating TRPA1 ion channels. Advanced healthcare materials. 11(8):2102506, 2022.","journal-title":"Advanced healthcare materials"},{"issue":"19","key":"3963_CR145","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.3390\/molecules27196608","volume":"27","author":"SA Mir","year":"2022","unstructured":"Mir, S. A., et al. Role of nanotechnology in overcoming the multidrug resistance in cancer therapy: A review. Molecules. 27(19):6608, 2022.","journal-title":"Molecules"},{"issue":"12","key":"3963_CR146","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1515\/nanoph-2021-0142","volume":"10","author":"T Saha","year":"2021","unstructured":"Saha, T., et al. Nanotherapeutic approaches to overcome distinct drug resistance barriers in models of breast cancer. Nanophotonics. 10(12):3063\u20133073, 2021.","journal-title":"Nanophotonics"},{"issue":"9","key":"3963_CR147","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.3390\/ijms22094673","volume":"22","author":"V Gote","year":"2021","unstructured":"Gote, V., et al. Drug resistance in metastatic breast cancer: tumor targeted nanomedicine to the rescue. International journal of molecular sciences. 22(9):4673, 2021.","journal-title":"International journal of molecular sciences"},{"issue":"4","key":"3963_CR148","first-page":"930","volume":"3","author":"H Islam","year":"2020","unstructured":"Islam, H., and E. Ahmed. Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance. Cancer Drug Resistance. 3(4):930\u2013946, 2020.","journal-title":"Cancer Drug Resistance"},{"issue":"5","key":"3963_CR149","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10379","volume":"8","author":"A Banstola","year":"2023","unstructured":"Banstola, A., et al. Reactive oxygen species-responsive dual-targeted nanosystem promoted immunogenic cell death against breast cancer. Bioengineering & Translational Medicine.8(5):e10379, 2023.","journal-title":"Bioengineering & Translational Medicine"},{"issue":"11","key":"3963_CR150","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1016\/j.apsb.2020.05.008","volume":"10","author":"J Li","year":"2020","unstructured":"Li, J., and D. J. Burgess. Nanomedicine-based drug delivery towards tumor biological and immunological microenvironment. Acta Pharmaceutica Sinica B. 10(11):2110\u20132124, 2020.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"3963_CR151","doi-asserted-by":"crossref","unstructured":"Zheng, D., et al., Her2-targeted multifunctional nano-theranostic platform mediates tumor microenvironment remodeling and immune activation for breast cancer treatment. International journal of nanomedicine, 2020: p. 10007\u201310028.","DOI":"10.2147\/IJN.S271213"},{"key":"3963_CR152","doi-asserted-by":"crossref","unstructured":"Yang, J., et al., Targeting tumor vasculature to enhance cancer immunotherapy. 2023, Frontiers Media SA. p. 1199811.","DOI":"10.3389\/fonc.2023.1199811"},{"issue":"3","key":"3963_CR153","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1021\/acs.nanolett.2c04312","volume":"23","author":"Y Wu","year":"2023","unstructured":"Wu, Y., et al. Nitric oxide-loaded bioinspired lipoprotein normalizes tumor vessels to improve intratumor delivery and chemotherapy of albumin-bound paclitaxel nanoparticles. Nano Letters. 23(3):939\u2013947, 2023.","journal-title":"Nano Letters"},{"issue":"31","key":"3963_CR154","doi-asserted-by":"publisher","first-page":"2209799","DOI":"10.1002\/adma.202209799","volume":"35","author":"J Wan","year":"2023","unstructured":"Wan, J., et al. Biodegradable NIR-II Pseudo Conjugate Polymeric Nanoparticles Amplify Photodynamic Immunotherapy via Alleviation of Tumor Hypoxia and Tumor-Associated Macrophage Reprogramming. Advanced Materials. 35(31):2209799, 2023.","journal-title":"Advanced Materials"},{"issue":"5","key":"3963_CR155","doi-asserted-by":"publisher","first-page":"1802070","DOI":"10.1002\/advs.201802070","volume":"6","author":"Y Chen","year":"2019","unstructured":"Chen, Y., et al. Therapeutic remodeling of the tumor microenvironment enhances nanoparticle delivery. Advanced Science. 6(5):1802070, 2019.","journal-title":"Advanced Science"},{"key":"3963_CR156","doi-asserted-by":"crossref","unstructured":"Jia, N., et al., Membrane Fusion Liposomes Deliver Antifibrotic and Chemotherapeutic Drugs Sequentially to Enhance Tumor Treatment Efficacy by Reshaping Tumor Microenvironment. Advanced Healthcare Materials, 2024: p. 2400219.","DOI":"10.1002\/adhm.202400219"},{"issue":"5","key":"3963_CR157","doi-asserted-by":"publisher","DOI":"10.1088\/2057-1976\/ad6f15","volume":"10","author":"Z Razavi","year":"2024","unstructured":"Razavi, Z., et al. Microfluidic systems for modeling digestive cancer: a review of recent progress. Biomedical Physics & Engineering Express.10(5):052002, 2024.","journal-title":"Biomedical Physics & Engineering Express"},{"issue":"643","key":"3963_CR158","doi-asserted-by":"publisher","first-page":"eabl3649","DOI":"10.1126\/scitranslmed.abl3649","volume":"14","author":"Y Song","year":"2022","unstructured":"Song, Y., et al. Albumin nanoparticle containing a PI3K\u03b3 inhibitor and paclitaxel in combination with \u03b1-PD1 induces tumor remission of breast cancer in mice. Science translational medicine. 14(643):eabl3649, 2022.","journal-title":"Science translational medicine"},{"key":"3963_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.750847","volume":"12","author":"H Zhang","year":"2021","unstructured":"Zhang, H., et al. Synergistic cascade strategy based on modifying tumor microenvironment for enhanced breast cancer therapy. Frontiers in Pharmacology.12:750847, 2021.","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"3963_CR160","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1021\/acs.molpharmaceut.9b00812","volume":"17","author":"S Stras","year":"2019","unstructured":"Stras, S., et al. Growth of metastatic triple-negative breast cancer is inhibited by deep tumor-penetrating and slow tumor-clearing chemotherapy: the case of tumor-adhering liposomes with interstitial drug release. Molecular pharmaceutics. 17(1):118\u2013131, 2019.","journal-title":"Molecular pharmaceutics"},{"issue":"1","key":"3963_CR161","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12951-022-01476-9","volume":"20","author":"GSR Raju","year":"2022","unstructured":"Raju, G. S. R., et al. Nanoparticles mediated tumor microenvironment modulation: current advances and applications. Journal of Nanobiotechnology. 20(1):274, 2022.","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"3963_CR162","doi-asserted-by":"publisher","first-page":"10","DOI":"10.53747\/nst.v13i1.410","volume":"13","author":"TM Pham","year":"2023","unstructured":"Pham, T. M., P. M. T. Mai, and T. M. H. Le. Study on preparation of Fe\u2083O\u2084@ lapatinib nanoparticles for application as a targeted drug delivery system in the treatment of breast cancer. Nuclear Science and Technology. 13(1):10\u201318, 2023.","journal-title":"Nuclear Science and Technology"},{"issue":"36","key":"3963_CR163","doi-asserted-by":"publisher","first-page":"42","DOI":"10.9734\/jpri\/2020\/v32i3630991","volume":"32","author":"SB Diwate","year":"2020","unstructured":"Diwate, S. B., Z. Ataurrahman, and K. S. Bhise. Trends in nanotechnology for the treatment of breast cancer. Journal of Pharmaceutical Research International. 32(36):42\u201357, 2020.","journal-title":"Journal of Pharmaceutical Research International"},{"key":"3963_CR164","first-page":"5","volume":"9","author":"MFA Khan","year":"2021","unstructured":"Khan, M. F. A., and N. Khan. Theranostic Applications of Magnetic Nanoparticles in Breast Cancer. 9:5\u20132021, 2021.","journal-title":"Theranostic Applications of Magnetic Nanoparticles in Breast Cancer."},{"issue":"26","key":"3963_CR165","doi-asserted-by":"publisher","first-page":"8073","DOI":"10.7150\/thno.37198","volume":"9","author":"J Park","year":"2019","unstructured":"Park, J., et al. Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment. Theranostics. 9(26):8073, 2019.","journal-title":"Theranostics"},{"key":"3963_CR166","doi-asserted-by":"publisher","first-page":"333","DOI":"10.22159\/ijap.2019v11i4.31134","volume":"11","author":"ID Raut","year":"2019","unstructured":"Raut, I. D., et al. Design, development and characterization of paclitaxel loaded solid lipid nanoparticles as a colloidal drug carrier. Int J Appl Pharm. 11:333\u201340, 2019.","journal-title":"Int J Appl Pharm"},{"key":"3963_CR167","doi-asserted-by":"publisher","first-page":"0016","DOI":"10.34133\/bmef.0016","volume":"4","author":"WC Chan","year":"2023","unstructured":"Chan, W. C. Principles of nanoparticle delivery to solid tumors. BME frontiers. 4:0016, 2023.","journal-title":"BME frontiers"},{"issue":"11","key":"3963_CR168","volume":"32","author":"P Shadmani","year":"2019","unstructured":"Shadmani, P., et al. Protein corona impact on nanoparticle-cell interactions: Toward an energy-based model of endocytosis. Journal of Physics: Condensed Matter.32(11):115101, 2019.","journal-title":"Journal of Physics: Condensed Matter"},{"issue":"3","key":"3963_CR169","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1021\/acsnano.2c05733","volume":"17","author":"A Fluksman","year":"2022","unstructured":"Fluksman, A., et al. Efficient tumor eradication at ultralow drug concentration via externally controlled and boosted metallic iron magnetoplasmonic nanocapsules. ACS nano. 17(3):1946\u20131958, 2022.","journal-title":"ACS nano"},{"issue":"23","key":"3963_CR170","doi-asserted-by":"publisher","first-page":"13169","DOI":"10.3390\/ijms222313169","volume":"22","author":"H-M Yoon","year":"2021","unstructured":"Yoon, H.-M., et al. Stimuli-responsive drug delivery of doxorubicin using magnetic nanoparticle conjugated poly (ethylene glycol)-g-chitosan copolymer. International Journal of Molecular Sciences. 22(23):13169, 2021.","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"3963_CR171","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1158\/1535-7163.MCT-18-0696","volume":"17","author":"W Islam","year":"2018","unstructured":"Islam, W., et al. Augmentation of the Enhanced Permeability and Retention Effect with Nitric Oxide-Generating Agents Improves the Therapeutic Effects of Nanomedicines. Mol Cancer Ther. 17(12):2643\u20132653, 2018.","journal-title":"Mol Cancer Ther"},{"issue":"Pt 2","key":"3963_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2023.117292","volume":"239","author":"S Amiri","year":"2023","unstructured":"Amiri, S., et al. Co-encapsulation of hydrophilic and hydrophobic drugs into niosomal nanocarrier for enhanced breast cancer therapy: In silico and in vitro studies. Environ Res.239(Pt 2):117292, 2023.","journal-title":"Environ Res"},{"issue":"4","key":"3963_CR173","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.3109\/10717544.2014.990651","volume":"23","author":"J Tang","year":"2016","unstructured":"Tang, J., et al. Co-delivery of doxorubicin and P-gp inhibitor by a reduction-sensitive liposome to overcome multidrug resistance, enhance anti-tumor efficiency and reduce toxicity. Drug Deliv. 23(4):1130\u20131143, 2016.","journal-title":"Drug Deliv"},{"key":"3963_CR174","doi-asserted-by":"crossref","unstructured":"Razavi, Z.S., et al., Stem cells and bio scaffolds for the treatment of cardiovascular diseases: new insights. Frontiers in Cell and Developmental Biology, 2024. Volume 12 - 2024.","DOI":"10.3389\/fcell.2024.1472103"},{"key":"3963_CR175","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jconrel.2023.08.006","volume":"361","author":"BL Nguyen","year":"2023","unstructured":"Nguyen, B. L., et al. Liposomal co-delivery of toll-like receptors 3 and 7 agonists induce a hot triple-negative breast cancer immune environment. J Control Release. 361:443\u2013454, 2023.","journal-title":"J Control Release"},{"issue":"11","key":"3963_CR176","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1021\/ja0564261","volume":"128","author":"EV Shevchenko","year":"2006","unstructured":"Shevchenko, E. V., et al. Structural characterization of self-assembled multifunctional binary nanoparticle superlattices. J Am Chem Soc. 128(11):3620\u20133637, 2006.","journal-title":"J Am Chem Soc"},{"issue":"1","key":"3963_CR177","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10517-024-06147-3","volume":"177","author":"VV Kudelkina","year":"2024","unstructured":"Kudelkina, V. V., et al. Characteristics of the Antitumor Effect of Doxorubicin and Pegylated Hyaluronidase on Models of Rat Brain Tumors. Bull Exp Biol Med. 177(1):147\u2013154, 2024.","journal-title":"Bull Exp Biol Med"},{"key":"3963_CR178","doi-asserted-by":"crossref","unstructured":"Wolfson, B., et al., Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing. J Immunother Cancer, 2021. 9(7).","DOI":"10.1136\/jitc-2020-002258"},{"issue":"4","key":"3963_CR179","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/wnan.1381","volume":"8","author":"TK Hill","year":"2016","unstructured":"Hill, T. K., and A. M. Mohs. Image-guided tumor surgery: will there be a role for fluorescent nanoparticles? Wiley Interdiscip Rev Nanomed Nanobiotechnol. 8(4):498\u2013511, 2016.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"13","key":"3963_CR180","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1039\/C9TB02328C","volume":"8","author":"C Xu","year":"2020","unstructured":"Xu, C., et al. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer. J Mater Chem B. 8(13):2726\u20132737, 2020.","journal-title":"J Mater Chem B"},{"issue":"3","key":"3963_CR181","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s10549-022-06637-w","volume":"196","author":"K Reinhardt","year":"2022","unstructured":"Reinhardt, K., et al. PIK3CA-mutations in breast cancer. Breast Cancer Res Treat. 196(3):483\u2013493, 2022.","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"3963_CR182","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2217\/pgs-2020-0106","volume":"21","author":"Q Xiao","year":"2020","unstructured":"Xiao, Q., Y. Zhou, and V. M. Lauschke. Impact of variants in ATP-binding cassette transporters on breast cancer treatment. Pharmacogenomics. 21(18):1299\u20131310, 2020.","journal-title":"Pharmacogenomics"},{"issue":"3","key":"3963_CR183","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3390\/molecules25030715","volume":"25","author":"P de la Torre","year":"2020","unstructured":"de la Torre, P., et al. Cell-based nanoparticles delivery systems for targeted cancer therapy: lessons from anti-angiogenesis treatments. Molecules. 25(3):715, 2020.","journal-title":"Molecules"},{"issue":"1","key":"3963_CR184","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00403-024-03790-8","volume":"317","author":"ZS Razavi","year":"2025","unstructured":"Razavi, Z. S., et al. Application of novel strategies in chronic wound management with focusing on pressure ulcers: new perspective. Archives of Dermatological Research. 317(1):320, 2025.","journal-title":"Archives of Dermatological Research"},{"issue":"1","key":"3963_CR185","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12935-025-03741-x","volume":"25","author":"S Kamrani","year":"2025","unstructured":"Kamrani, S., et al. Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword. Cancer Cell International. 25(1):117, 2025.","journal-title":"Cancer Cell International"},{"issue":"3","key":"3963_CR186","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s12291-024-01219-7","volume":"40","author":"G Pouyamanesh","year":"2025","unstructured":"Pouyamanesh, G., et al. Thymol Enhances 5-Fluorouracil Cytotoxicity by Reducing Migration and Increasing Apoptosis and Cell Cycle Arrest in Esophageal Cancer Cells: An In-vitro Study. Indian J Clin Biochem. 40(3):422\u2013433, 2025.","journal-title":"Indian J Clin Biochem"},{"key":"3963_CR187","doi-asserted-by":"crossref","unstructured":"Razavi, Z.-S., et al., Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective. Frontiers in Bioengineering and Biotechnology, 2024. Volume 12 - 2024.","DOI":"10.3389\/fbioe.2024.1385124"},{"issue":"4","key":"3963_CR188","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/bioengineering12040341","volume":"12","author":"A Andavar","year":"2025","unstructured":"Andavar, A., et al. Current Research in Drug-Free Cancer Therapies. Bioengineering. 12(4):341, 2025.","journal-title":"Bioengineering"},{"key":"3963_CR189","doi-asserted-by":"publisher","first-page":"1296091","DOI":"10.3389\/fonc.2024.1296091","volume":"14","author":"I Waheed","year":"2024","unstructured":"Waheed, I., et al. Lipid-based nanoparticles as drug delivery carriers for cancer therapy. Front Oncol. 14:1296091, 2024.","journal-title":"Front Oncol"},{"issue":"1","key":"3963_CR190","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/v10019-011-0001-z","volume":"45","author":"S Prijic","year":"2011","unstructured":"Prijic, S., and G. Sersa. Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol. 45(1):1\u201316, 2011.","journal-title":"Radiol Oncol"},{"issue":"1","key":"3963_CR191","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s40001-025-02696-z","volume":"30","author":"YA Fahim","year":"2025","unstructured":"Fahim, Y. A., I. W. Hasani, and W. Mahmoud Ragab. Promising biomedical applications using superparamagnetic nanoparticles. Eur J Med Res. 30(1):441, 2025.","journal-title":"Eur J Med Res."},{"key":"3963_CR192","doi-asserted-by":"crossref","unstructured":"Mahmoudvand, G., et al., Mesenchymal stem cell therapy for non-healing diabetic foot ulcer infection: New insight. Frontiers in Bioengineering and Biotechnology, 2023. Volume 11 - 2023.","DOI":"10.3389\/fbioe.2023.1158484"},{"issue":"4","key":"3963_CR193","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4103\/0250-474X.57282","volume":"71","author":"S Mukherjee","year":"2009","unstructured":"Mukherjee, S., S. Ray, and R. S. Thakur. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. 71(4):349\u2013358, 2009.","journal-title":"Indian J Pharm Sci"},{"key":"3963_CR194","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.bcp.2017.09.006","volume":"145","author":"P Tiet","year":"2017","unstructured":"Tiet, P., and J. M. Berlin. Exploiting homing abilities of cell carriers: Targeted delivery of nanoparticles for cancer therapy. Biochem Pharmacol. 145:18\u201326, 2017.","journal-title":"Biochem Pharmacol"},{"key":"3963_CR195","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118491","volume":"272","author":"M Ashrafizadeh","year":"2021","unstructured":"Ashrafizadeh, M., et al. Hyaluronic acid-based nanoplatforms for Doxorubicin: A review of stimuli-responsive carriers, co-delivery and resistance suppression. Carbohydrate Polymers.272:118491, 2021.","journal-title":"Carbohydrate Polymers"},{"issue":"5","key":"3963_CR196","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","volume":"141","author":"R Bazak","year":"2015","unstructured":"Bazak, R., et al. Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol. 141(5):769\u2013784, 2015.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3963_CR197","doi-asserted-by":"publisher","first-page":"tkae021","DOI":"10.1093\/burnst\/tkae021","volume":"12","author":"A Fakouri","year":"2024","unstructured":"Fakouri, A., et al. Applications of mesenchymal stem cell-exosome components in wound infection healing: new insights. Burns & Trauma. 12:tkae021, 2024.","journal-title":"Burns & Trauma"},{"issue":"8","key":"3963_CR198","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.drudis.2022.04.011","volume":"27","author":"N Khan","year":"2022","unstructured":"Khan, N., et al. Recent advances in dual-ligand targeted nanocarriers for cancer therapy. Drug Discovery Today. 27(8):2288\u20132299, 2022.","journal-title":"Drug Discovery Today"},{"issue":"7","key":"3963_CR199","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.1021\/acsabm.5c00649","volume":"8","author":"S Nuchpun","year":"2025","unstructured":"Nuchpun, S., et al. Uptake Mechanism of Riboflavin-Functionalized Superparamagnetic Iron Oxide Nanoparticles in Triple-Negative Breast Cancer Cells. ACS Appl Bio Mater. 8(7):6088\u20136099, 2025.","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"3963_CR200","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","volume":"24","author":"H Sabit","year":"2025","unstructured":"Sabit, H., et al. Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery. Mol Cancer. 24(1):160, 2025.","journal-title":"Mol Cancer"},{"key":"3963_CR201","doi-asserted-by":"publisher","first-page":"1389775","DOI":"10.3389\/fonc.2024.1389775","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., and J. Wang. Research progress of cell membrane biomimetic nanoparticles for circulating tumor cells. Front Oncol. 14:1389775, 2024.","journal-title":"Front Oncol"},{"key":"3963_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.inoche.2025.114533","volume":"178","author":"FS Razavi","year":"2025","unstructured":"Razavi, F. S., Z. S. Razavi, and H. Shahsavari. Advanced synthesis and biomedical applications of colloidal quantum dots: Innovations in Imaging, drug delivery, and theranostics. Inorganic Chemistry Communications.178:114533, 2025.","journal-title":"Inorganic Chemistry Communications"},{"key":"3963_CR203","doi-asserted-by":"crossref","unstructured":"Sitia, L., et al., HER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment. Cancers (Basel), 2022. 14(10).","DOI":"10.3390\/cancers14102424"},{"key":"3963_CR204","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.smim.2017.09.002","volume":"34","author":"H Shen","year":"2017","unstructured":"Shen, H., et al. Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells. Semin Immunol. 34:114\u2013122, 2017.","journal-title":"Semin Immunol"},{"key":"3963_CR205","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev-bioeng-071812-152409","volume":"15","author":"G Bao","year":"2013","unstructured":"Bao, G., S. Mitragotri, and S. Tong. Multifunctional nanoparticles for drug delivery and molecular imaging. Annu Rev Biomed Eng. 15:253\u2013282, 2013.","journal-title":"Annu Rev Biomed Eng"},{"issue":"3","key":"3963_CR206","doi-asserted-by":"publisher","first-page":"4450","DOI":"10.1021\/acsnano.0c08384","volume":"15","author":"J Wagner","year":"2021","unstructured":"Wagner, J., et al. Mesoporous Silica Nanoparticles as pH-Responsive Carrier for the Immune-Activating Drug Resiquimod Enhance the Local Immune Response in Mice. ACS Nano. 15(3):4450\u20134466, 2021.","journal-title":"ACS Nano"},{"key":"3963_CR207","doi-asserted-by":"crossref","unstructured":"Tsai, C.C., et al., Integrins and Actions of Androgen in Breast Cancer. Cells, 2023. 12(17).","DOI":"10.3390\/cells12172126"},{"issue":"6","key":"3963_CR208","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3177\/jnsv.65.459","volume":"65","author":"X Chen","year":"2019","unstructured":"Chen, X., et al. Association of Intake Folate and Related Gene Polymorphisms with Breast Cancer. J Nutr Sci Vitaminol (Tokyo). 65(6):459\u2013469, 2019.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"2","key":"3963_CR209","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1406281","volume":"372","author":"SM Tolaney","year":"2015","unstructured":"Tolaney, S. M., et al. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer. N Engl J Med. 372(2):134\u2013141, 2015.","journal-title":"N Engl J Med"},{"issue":"1","key":"3963_CR210","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ultrasmedbio.2013.09.001","volume":"40","author":"F Yan","year":"2014","unstructured":"Yan, F., et al. A novel microfluidic chip for assessing dynamic adhesion behavior of cell-targeting microbubbles. Ultrasound Med Biol. 40(1):148\u2013157, 2014.","journal-title":"Ultrasound Med Biol"},{"key":"3963_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125186","volume":"670","author":"Z Sadat Razavi","year":"2025","unstructured":"Sadat Razavi, Z., et al. Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration. International Journal of Pharmaceutics.670:125186, 2025.","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"3963_CR212","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s10571-025-01563-z","volume":"45","author":"B Babaalizadeh","year":"2025","unstructured":"Babaalizadeh, B., et al. Role of Nuclear Receptors on the Progression of Multiple Sclerosis: A Review. Cellular and Molecular Neurobiology. 45(1):58, 2025.","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"4","key":"3963_CR213","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/1061186X.2015.1077850","volume":"24","author":"W Fan","year":"2016","unstructured":"Fan, W., et al. Thioaptamer-conjugated CD44-targeted delivery system for the treatment of breast cancer in vitro and in vivo. J Drug Target. 24(4):359\u2013371, 2016.","journal-title":"J Drug Target"},{"key":"3963_CR214","doi-asserted-by":"crossref","unstructured":"Gote, V., A.D. Sharma, and D. Pal, Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells. Int J Mol Sci, 2021. 22(3).","DOI":"10.3390\/ijms22031257"},{"key":"3963_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108253","volume":"237","author":"JY So","year":"2022","unstructured":"So, J. Y., et al. Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options. Pharmacol Ther.237:108253, 2022.","journal-title":"Pharmacol Ther"},{"key":"3963_CR216","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biomaterials.2017.10.035","volume":"152","author":"J Miller-Kleinhenz","year":"2018","unstructured":"Miller-Kleinhenz, J., et al. Dual-targeting Wnt and uPA receptors using peptide conjugated ultra-small nanoparticle drug carriers inhibited cancer stem-cell phenotype in chemo-resistant breast cancer. Biomaterials. 152:47\u201362, 2018.","journal-title":"Biomaterials"},{"issue":"13","key":"3963_CR217","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1158\/1078-0432.CCR-13-2769","volume":"20","author":"NA O'Brien","year":"2014","unstructured":"O\u2019Brien, N. A., et al. Targeting PI3K\/mTOR overcomes resistance to HER2-targeted therapy independent of feedback activation of AKT. Clin Cancer Res. 20(13):3507\u20133520, 2014.","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3963_CR218","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.201800207","volume":"18","author":"SCT Moorcroft","year":"2018","unstructured":"Moorcroft, S. C. T., et al. Stimuli-Responsive Release of Antimicrobials Using Hybrid Inorganic Nanoparticle-Associated Drug-Delivery Systems. Macromol Biosci.18(12):e1800207, 2018.","journal-title":"Macromol Biosci"},{"issue":"23","key":"3963_CR219","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/smll.200900621","volume":"5","author":"AM Chen","year":"2009","unstructured":"Chen, A. M., et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small. 5(23):2673\u20132677, 2009.","journal-title":"Small"},{"key":"3963_CR220","doi-asserted-by":"crossref","unstructured":"Xu, M., et al., Cancer Nanomedicine: Emerging Strategies and Therapeutic Potentials. Molecules, 2023. 28(13).","DOI":"10.3390\/molecules28135145"},{"key":"3963_CR221","doi-asserted-by":"crossref","unstructured":"Razavi, Z.S. and H. Afkhami, Advancing Congenital Heart Defect Treatments: Synergistic Approaches with Stem Cells and Functional Scaffolds. Stem Cell Reviews and Reports, 2025.","DOI":"10.1007\/s12015-025-10996-4"},{"issue":"1","key":"3963_CR222","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s11033-024-09250-w","volume":"51","author":"G Taheripak","year":"2024","unstructured":"Taheripak, G., et al. SIRT1 activation attenuates palmitate induced apoptosis in C2C12 muscle cells. Molecular Biology Reports. 51(1):354, 2024.","journal-title":"Molecular Biology Reports"},{"issue":"12","key":"3963_CR223","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ccell.2021.09.010","volume":"39","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., et al. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell. 39(12):1578-1593.e8, 2021.","journal-title":"Cancer Cell"},{"issue":"37","key":"3963_CR224","doi-asserted-by":"publisher","first-page":"eaau6584","DOI":"10.1126\/sciimmunol.aau6584","volume":"4","author":"D Wang","year":"2019","unstructured":"Wang, D., et al. Engineering nanoparticles to locally activate T cells in the tumor microenvironment. Science immunology. 4(37):eaau6584, 2019.","journal-title":"Science immunology"},{"issue":"2","key":"3963_CR225","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2147\/IJN.S596","volume":"3","author":"WH De Jong","year":"2008","unstructured":"De Jong, W. H., and P. J. Borm. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine. 3(2):133\u2013149, 2008.","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"3963_CR226","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.apsb.2022.07.011","volume":"13","author":"K Butowska","year":"2023","unstructured":"Butowska, K., et al. Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy. Acta Pharm Sin B. 13(4):1429\u20131437, 2023.","journal-title":"Acta Pharm Sin B"},{"issue":"32","key":"3963_CR227","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1021\/la302546m","volume":"28","author":"X He","year":"2012","unstructured":"He, X., et al. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties. Langmuir. 28(32):11929\u201311938, 2012.","journal-title":"Langmuir"},{"issue":"3","key":"3963_CR228","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.devcel.2020.12.016","volume":"56","author":"M Hao","year":"2021","unstructured":"Hao, M., et al. Autophagy Blockade Limits HER2+ Breast Cancer Tumorigenesis by Perturbing HER2 Trafficking and Promoting Release Via Small Extracellular Vesicles. Dev Cell. 56(3):341-355.e5, 2021.","journal-title":"Dev Cell"},{"key":"3963_CR229","doi-asserted-by":"crossref","unstructured":"Xu, J., et al., pH and GSH dual-responsive drug-controlled nanomicelles for breast cancer treatment. Biomed Mater, 2023. 18(2).","DOI":"10.1088\/1748-605X\/acb7bb"},{"key":"3963_CR230","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.actbio.2015.01.039","volume":"16","author":"H Xu","year":"2015","unstructured":"Xu, H., et al. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation. Acta Biomater. 16:156\u2013168, 2015.","journal-title":"Acta Biomater"},{"key":"3963_CR231","doi-asserted-by":"crossref","unstructured":"Feng, C., et al., Precisely Tailoring Molecular Structure of Doxorubicin Prodrugs to Enable Stable Nanoassembly, Rapid Activation, and Potent Antitumor Effect. Pharmaceutics, 2024. 16(12).","DOI":"10.3390\/pharmaceutics16121582"},{"key":"3963_CR232","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.actbio.2015.11.041","volume":"31","author":"W Zheng","year":"2016","unstructured":"Zheng, W., et al. Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III \u03b2-tubulin in drug-resistant breast cancers. Acta Biomater. 31:197\u2013210, 2016.","journal-title":"Acta Biomater"},{"issue":"1","key":"3963_CR233","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12951-022-01576-6","volume":"20","author":"R Wang","year":"2022","unstructured":"Wang, R., et al. Biologically synthesized black ginger-selenium nanoparticle induces apoptosis and autophagy of AGS gastric cancer cells by suppressing the PI3K\/Akt\/mTOR signaling pathway. J Nanobiotechnology. 20(1):441, 2022.","journal-title":"J Nanobiotechnology"},{"issue":"Pt 3","key":"3963_CR234","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119126","volume":"338","author":"J Zhou","year":"2025","unstructured":"Zhou, J., et al. Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer. J Ethnopharmacol.338(Pt 3):119126, 2025.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"3963_CR235","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3892\/br.2021.1418","volume":"14","author":"S Sim","year":"2021","unstructured":"Sim, S., and N. K. Wong. Nanotechnology and its use in imaging and drug delivery (Review). Biomed Rep. 14(5):42, 2021.","journal-title":"Biomed Rep"},{"key":"3963_CR236","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.copbio.2021.12.011","volume":"74","author":"A Singh","year":"2022","unstructured":"Singh, A., and M. M. Amiji. Application of nanotechnology in medical diagnosis and imaging. Curr Opin Biotechnol. 74:241\u2013246, 2022.","journal-title":"Curr Opin Biotechnol"},{"key":"3963_CR237","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Medina, C., et al., Integrating nanomedicine and imaging. Philos Trans A Math Phys Eng Sci, 2017. 375(2107).","DOI":"10.1098\/rsta.2017.0110"},{"key":"3963_CR238","doi-asserted-by":"crossref","unstructured":"Wo\u017aniak, M., et al., Molecular Imaging and Nanotechnology-Emerging Tools in Diagnostics and Therapy. Int J Mol Sci, 2022. 23(5).","DOI":"10.3390\/ijms23052658"},{"issue":"1","key":"3963_CR239","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12951-021-01232-5","volume":"20","author":"S Qi","year":"2022","unstructured":"Qi, S., et al. The bright future of nanotechnology in lymphatic system imaging and imaging-guided surgery. J Nanobiotechnology. 20(1):24, 2022.","journal-title":"J Nanobiotechnology"},{"issue":"3","key":"3963_CR240","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11307-017-1056-z","volume":"19","author":"C Andreou","year":"2017","unstructured":"Andreou, C., et al. Molecular Imaging in Nanotechnology and Theranostics. Mol Imaging Biol. 19(3):363\u2013372, 2017.","journal-title":"Mol Imaging Biol"},{"issue":"56","key":"3963_CR241","doi-asserted-by":"publisher","first-page":"35392","DOI":"10.1039\/D1RA01947C","volume":"11","author":"X Li","year":"2021","unstructured":"Li, X., et al. Nanotechnology-based strategies for gastric cancer imaging and treatment. RSC Adv. 11(56):35392\u201335407, 2021.","journal-title":"RSC Adv"},{"issue":"4","key":"3963_CR242","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2174\/1874471016666230621120453","volume":"16","author":"S Singh","year":"2023","unstructured":"Singh, S., and H. Sharma. Emerging Applications of Nanotechnology in Drug Delivery and Medical Imaging: Review. Curr Radiopharm. 16(4):269\u2013283, 2023.","journal-title":"Curr Radiopharm"},{"key":"3963_CR243","doi-asserted-by":"crossref","unstructured":"Domb, A.J., et al., Safety Evaluation of Nanotechnology Products. Pharmaceutics, 2021. 13(10).","DOI":"10.3390\/pharmaceutics13101615"},{"issue":"14","key":"3963_CR244","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1111\/febs.16768","volume":"290","author":"L Zhou","year":"2023","unstructured":"Zhou, L., et al. MAEL facilitates metabolic reprogramming and breast cancer progression by promoting the degradation of citrate synthase and fumarate hydratase via chaperone-mediated autophagy. Febs j. 290(14):3614\u20133628, 2023.","journal-title":"Febs j"},{"key":"3963_CR245","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jconrel.2023.10.032","volume":"364","author":"Y Sun","year":"2023","unstructured":"Sun, Y., et al. Nanomedicine-mediated regulated cell death in cancer immunotherapy. J Control Release. 364:174\u2013194, 2023.","journal-title":"J Control Release"},{"key":"3963_CR246","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2021.108407","volume":"789","author":"TS Kumaravel","year":"2022","unstructured":"Kumaravel, T. S., et al. Genotoxicity evaluation of medical devices: A regulatory perspective. Mutat Res Rev Mutat Res.789:108407, 2022.","journal-title":"Mutat Res Rev Mutat Res"},{"issue":"2","key":"3963_CR247","doi-asserted-by":"publisher","first-page":"110","DOI":"10.2174\/1389200218666171031122346","volume":"19","author":"T Luo","year":"2018","unstructured":"Luo, T., et al. Genotoxicity of Nanocarriers. Curr Drug Metab. 19(2):110\u2013123, 2018.","journal-title":"Curr Drug Metab"},{"issue":"6","key":"3963_CR248","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1833","volume":"14","author":"R Landsiedel","year":"2022","unstructured":"Landsiedel, R., et al. Genotoxicity testing of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol.14(6):e1833, 2022.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"3963_CR249","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.665810","volume":"12","author":"Q Ma","year":"2021","unstructured":"Ma, Q., et al. Editorial: Immune Mechanisms in the Pathologic Response to Particles, Fibers, and Nanomaterials. Front Immunol.12:665810, 2021.","journal-title":"Front Immunol"},{"issue":"9","key":"3963_CR250","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1039\/D0BM00129E","volume":"8","author":"L Huang","year":"2020","unstructured":"Huang, L., et al. Nanomedicine - a promising therapy for hematological malignancies. Biomater Sci. 8(9):2376\u20132393, 2020.","journal-title":"Biomater Sci"},{"issue":"10","key":"3963_CR251","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1080\/14760584.2021.1984890","volume":"20","author":"A Das","year":"2021","unstructured":"Das, A., and N. Ali. Nanovaccine: an emerging strategy. Expert Rev Vaccines. 20(10):1273\u20131290, 2021.","journal-title":"Expert Rev Vaccines"},{"issue":"17","key":"3963_CR252","doi-asserted-by":"publisher","first-page":"11476","DOI":"10.1021\/acs.chemrev.7b00194","volume":"117","author":"C Kinnear","year":"2017","unstructured":"Kinnear, C., et al. Form Follows Function: Nanoparticle Shape and Its Implications for Nanomedicine. Chem Rev. 117(17):11476\u201311521, 2017.","journal-title":"Chem Rev"},{"key":"3963_CR253","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jconrel.2023.03.019","volume":"356","author":"Y Wang","year":"2023","unstructured":"Wang, Y., et al. Charge-conversional click polyprodrug nanomedicine for targeted and synergistic cancer therapy. J Control Release. 356:567\u2013579, 2023.","journal-title":"J Control Release"},{"key":"3963_CR254","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.2147\/IJN.S415139","volume":"18","author":"R Huang","year":"2023","unstructured":"Huang, R., et al. Multi-Site Attack, Neutrophil Membrane-Camouflaged Nanomedicine with High Drug Loading for Enhanced Cancer Therapy and Metastasis Inhibition. Int J Nanomedicine. 18:3359\u20133375, 2023.","journal-title":"Int J Nanomedicine"},{"key":"3963_CR255","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.2147\/IJN.S432854","volume":"18","author":"D Fan","year":"2023","unstructured":"Fan, D., et al. Light-Assisted \u201cNano-Neutrophils\u201d with High Drug Loading for Targeted Cancer Therapy. Int J Nanomedicine. 18:6487\u20136502, 2023.","journal-title":"Int J Nanomedicine"},{"issue":"45","key":"3963_CR256","doi-asserted-by":"publisher","first-page":"20894","DOI":"10.1039\/C8NR04506B","volume":"10","author":"T John","year":"2018","unstructured":"John, T., et al. Impact of nanoparticles on amyloid peptide and protein aggregation: a review with a focus on gold nanoparticles. Nanoscale. 10(45):20894\u201320913, 2018.","journal-title":"Nanoscale"},{"issue":"46","key":"3963_CR257","doi-asserted-by":"publisher","first-page":"12320","DOI":"10.1002\/anie.201403036","volume":"53","author":"T Sun","year":"2014","unstructured":"Sun, T., et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 53(46):12320\u201312364, 2014.","journal-title":"Angew Chem Int Ed Engl"},{"key":"3963_CR258","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122320","volume":"628","author":"E Jaradat","year":"2022","unstructured":"Jaradat, E., et al. Microfluidic paclitaxel-loaded lipid nanoparticle formulations for chemotherapy. Int J Pharm.628:122320, 2022.","journal-title":"Int J Pharm"},{"issue":"22","key":"3963_CR259","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.2174\/13816128256661902011296290","volume":"27","author":"M Daniyal","year":"2020","unstructured":"Daniyal, M., B. Liu, and W. Wang. Comprehensive Review on Graphene Oxide for Use in Drug Delivery System. Curr Med Chem. 27(22):3665\u20133685, 2020.","journal-title":"Curr Med Chem"},{"issue":"31","key":"3963_CR260","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.2174\/0929867327666201111143725","volume":"28","author":"M Zhou","year":"2021","unstructured":"Zhou, M., et al. Recent Advances in Paclitaxel-based Self-Delivery Nanomedicine for Cancer Therapy. Curr Med Chem. 28(31):6358\u20136374, 2021.","journal-title":"Curr Med Chem"},{"issue":"9","key":"3963_CR261","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/cplu.202000496","volume":"85","author":"Y Liu","year":"2020","unstructured":"Liu, Y., et al. Development of High-Drug-Loading Nanoparticles. Chempluschem. 85(9):2143\u20132157, 2020.","journal-title":"Chempluschem"},{"key":"3963_CR262","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102278","volume":"35","author":"X Wang","year":"2025","unstructured":"Wang, X., et al. Carrier-free nanoparticles based on natural products trigger dual \u201csynergy and attenuation\u201d for enhanced phototherapy of liver cancer. Materials Today Bio.35:102278, 2025.","journal-title":"Materials Today Bio"},{"key":"3963_CR263","doi-asserted-by":"crossref","unstructured":"Su, S. and P.M. Kang, Systemic Review of Biodegradable Nanomaterials in Nanomedicine. Nanomaterials (Basel), 2020. 10(4).","DOI":"10.3390\/nano10040656"}],"container-title":["Annals of Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-025-03963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10439-025-03963-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10439-025-03963-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T21:02:27Z","timestamp":1779224547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10439-025-03963-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":263,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3963"],"URL":"https:\/\/doi.org\/10.1007\/s10439-025-03963-0","relation":{},"ISSN":["0090-6964","1573-9686"],"issn-type":[{"value":"0090-6964","type":"print"},{"value":"1573-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study is a review article, and therefore does not require ethics approval or consent for participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have consented to the publication of this review article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}